JPRN-UMIN000000801
Unknown
Phase 2
A phase II study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer. - A phase II study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer.
Dept. of Internal Medicine(4)0 sites30 target enrollmentStarted: August 15, 2007Last updated:
Conditionsadvanced gastric cancer
Overview
- Phase
- Phase 2
- Sponsor
- Dept. of Internal Medicine(4)
- Enrollment
- 30
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. A history of hypersensitivity reaction to drugs formulated with polysorbate 80\. 2\. Patients contraindicated to docetaxel, cisplatin, S\-1, or G\-CSF. 3\. Documented or suspected infection. 4\. Uncontrolled medical conditions (e.g., malignant hypertension, congestive heart failure, myocardial infarction in previous 3 months, arrhythmia requiring treatment, diabetes, interstitial pneumonia, pulmonary fibrosis). 5\. Grade 2 or greater peripheral neuropathy. 6\. Patients with brain metastasis 7\. Patients with diarrhea. 8\. Active concomitant malignancy. 9\. Pregnant or lactating women and women of child bearing potential not using contraception. 10\. Men with partner willing to get pregnant 11\. Patients judged by the investigator as unfit to be enrolled in the study. 12\. Patients already enrolled in this study.
Investigators
Similar Trials
Recruiting
Phase 2
The Phase II Study of Docetaxel plus Nedaplatin as Adjuvant Chemotherapy in Patients with Completely Resected Stage IB-IIIA Non-Small Cell Lung Canceron-small cell lung cancerJPRN-UMIN000004634Shiga University of Medical Science30
Completed
Phase 2
Multicenter phase II study of docetaxel/cisplatin/bevacizumab combination therapy in patients with advanced non-squamous non-small cell lung cancer (TORG1016)JPRN-UMIN000004368Thoracic Oncology Research Group47
Completed
Phase 2
Phase II study of the combination of docetaxel, cisplatin plus S-1(DCS) for advanced or recurrent gastric cancer(KDOG 0601)Gastric cancerJPRN-UMIN000001119Department of Gastroenterology, Kitasato University School of Medicine45
Completed
Phase 1
Phase I/II study of biweekly docetaxel, cisplatin, and S-1 combination neoadjuvant chemotherapy in patients with stage III gastric cancergastric cancerJPRN-UMIN000011625Yokohama City University Medical Center51
Active, not recruiting
Not Applicable
Phase II study: Treatment with the drug docetaxel and oxaliplatin for patients who have a confirmed metastatic or locally advanced cancer of the pancreas and in whom initial therapy has failed.EUCTR2005-004236-40-DEniversitätsklinikum Ulm44